Literature DB >> 16616479

Protein arginine methylation in lymphocyte signaling.

Fabien Blanchet1, Brandon T Schurter, Oreste Acuto.   

Abstract

Methylation of arginine is an additional option within the repertoire of post-translational modifications that proteins utilize for their communication with other partner proteins and nucleic acids, which ultimately contributes to cellular functions. Recent studies reveal that protein arginine methylation is more common and widespread than previously thought and that it is implicated in a number of key cellular processes including signal transduction. Two recent investigations have propelled this new world of protein modification into the immunological community by showing that TCR and CD28 signaling exploit this pathway. In contrast to other protein modifications utilized in intracellular signaling, arginine methylation seems to be long-lasting, raising interesting questions as to when, where and for what reason it can be utilized in the lymphocyte differentiation processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616479     DOI: 10.1016/j.coi.2006.03.001

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  11 in total

Review 1.  Small Molecule Inhibitors of Protein Arginine Methyltransferases.

Authors:  Hao Hu; Kun Qian; Meng-Chiao Ho; Y George Zheng
Journal:  Expert Opin Investig Drugs       Date:  2016-02-16       Impact factor: 6.206

Review 2.  Protein arginine methylation in parasitic protozoa.

Authors:  John C Fisk; Laurie K Read
Journal:  Eukaryot Cell       Date:  2011-06-17

Review 3.  Transmethylation in immunity and autoimmunity.

Authors:  Brian R Lawson; Theodoros Eleftheriadis; Virginie Tardif; Rosana Gonzalez-Quintial; Roberto Baccala; Dwight H Kono; Argyrios N Theofilopoulos
Journal:  Clin Immunol       Date:  2011-12-24       Impact factor: 3.969

4.  Critical role of transmethylation in TLR signaling and systemic lupus erythematosus.

Authors:  Virginie Tardif; Yulia Manenkova; Michael Berger; Kasper Hoebe; Jian-Ping Zuo; Chong Yuan; Dwight H Kono; Argyrios N Theofilopoulos; Brian R Lawson
Journal:  Clin Immunol       Date:  2013-03-05       Impact factor: 3.969

5.  Suppressive effects of tumor cell-derived 5'-deoxy-5'-methylthioadenosine on human T cells.

Authors:  Frederik C Henrich; Katrin Singer; Kerstin Poller; Luise Bernhardt; Carolin D Strobl; Katharina Limm; Axel P Ritter; Eva Gottfried; Simon Völkl; Benedikt Jacobs; Katrin Peter; Dimitrios Mougiakakos; Katja Dettmer; Peter J Oefner; Anja-Katrin Bosserhoff; Marina P Kreutz; Michael Aigner; Andreas Mackensen
Journal:  Oncoimmunology       Date:  2016-06-10       Impact factor: 8.110

Review 6.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

7.  Arginine methylation of the B cell antigen receptor promotes differentiation.

Authors:  Simona Infantino; Beate Benz; Tanja Waldmann; Manfred Jung; Robert Schneider; Michael Reth
Journal:  J Exp Med       Date:  2010-03-15       Impact factor: 14.307

Review 8.  Protein Arginine Methyltransferases (PRMTs): promising targets for the treatment of pulmonary disorders.

Authors:  Dariusz Zakrzewicz; Anna Zakrzewicz; Klaus T Preissner; Philipp Markart; Malgorzata Wygrecka
Journal:  Int J Mol Sci       Date:  2012-09-27       Impact factor: 5.923

9.  Arginine methylation catalyzed by PRMT1 is required for B cell activation and differentiation.

Authors:  Simona Infantino; Amanda Light; Kristy O'Donnell; Vanessa Bryant; Danielle T Avery; Michael Elliott; Stuart G Tangye; Gabrielle Belz; Fabienne Mackay; Stephane Richard; David Tarlinton
Journal:  Nat Commun       Date:  2017-10-12       Impact factor: 14.919

10.  Phosphoproteomics Reveals Regulatory T Cell-Mediated DEF6 Dephosphorylation That Affects Cytokine Expression in Human Conventional T Cells.

Authors:  Rubin N Joshi; Nadine A Binai; Francesco Marabita; Zhenhua Sui; Amnon Altman; Albert J R Heck; Jesper Tegnér; Angelika Schmidt
Journal:  Front Immunol       Date:  2017-09-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.